Home/Filings/4/A/0001493152-18-009665
4/A//SEC Filing

Anderson David Evander 4/A

Accession 0001493152-18-009665

CIK 0000764195other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 3:34 PM ET

Size

5.5 KB

Accession

0001493152-18-009665

Insider Transaction Report

Form 4/AAmended
Period: 2018-06-14
Anderson David Evander
Chief Scientific Officer
Transactions
  • Tax Payment

    Common Shares, no par value per share

    2018-06-14$3.76/sh9,281$34,897101,334 total
Footnotes (1)
  • [F1]On June 18, 2018, the reporting person filed a Form 4 which inadvertently reported that 9,306 common shares were withheld to satisfy the tax liability in connection with vesting of 21,875 restricted stock units and that the reporting person beneficially owns 101,309 shares following the reported transaction. In fact, as reported in this amendment, 9,281 common shares were withheld to satisfy the tax liability in connection with the vesting of restricted stock units, and the reporting person beneficially owns 101,334 common shares following the reported transaction.

Documents

1 file

Issuer

VBI Vaccines Inc/BC

CIK 0000764195

Entity typeother

Related Parties

1
  • filerCIK 0001616018

Filing Metadata

Form type
4/A
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 3:34 PM ET
Size
5.5 KB